Last month, we published our final news story and bulletin on infohep.
All our news, including conference reporting and email bulletins, information pages and country pages will continue to be accessible as an archive on https://t.co/y0TN2f9Yqi.
https://t.co/hqe3kH5LC4
.@aidsmap will continue to report stories on hepatitis and HIV co-infection https://t.co/A4uktFqMVb Thanks to all those who have supported this site with expertise & reporting, especially Keith Alcorn, @LizHighleyman, Ingo van Thiel of Deutsche Leberhilfe e.V., & our translators
Last month, we published our final news story and bulletin on infohep.
All our news, including conference reporting and email bulletins, information pages and country pages will continue to be accessible as an archive on https://t.co/y0TN2f9Yqi.
https://t.co/hqe3kH5LC4
News from the @AASLDtweets Liver Meeting: Some people remain at risk for liver cancer after being cured of hepatitis C #LiverMtg https://t.co/7CHgNHXzTD
Our summary bulletin of news from the @AASLDtweets Liver Meeting is now online: https://t.co/uGLysBfshU Translated editions will be available in the next week. #LiverMtg Sadly, this is also our final infohep bulletin.
News from the @AASLDtweets Liver Meeting: VIR-2218 combined with monoclonal antibody or pegylated interferon delivers potent suppression of hepatitis B https://t.co/kaX14rIVn9 #LiverMtg
News from the @AASLDtweets Liver Meeting: Bepirovirsen treatment leads to sustained loss of hepatitis B markers for up to one in five https://t.co/8ShnSPmfl5 #LiverMtg
News from the @AASLDtweets Liver Meeting: UK community test-and-treat service achieves high hepatitis C cure rate in people who use drugs https://t.co/mUtBGYIPtE #LiverMtg
News from the @AASLDtweets Liver Meeting: Simplified tenofovir regimen as effective as recommended preventive treatment in pregnant women with hepatitis B https://t.co/stfQHH1fFv #LiverMtg